Associate professor Tomas Kalincik is the head of the Multiple Sclerosis and Neuroimmunology Service at the Royal Melbourne Hospital and the head of the Clinical Outcomes Research (CORe) Unit at the University of Melbourne.
Tomas trained as a neurologist in the Czech Republic and he holds a degree in medicine/surgery from Charles University in Prague, PhD in neuroscience from the University of New South Wales and a Postgraduate Certificate of Biostatistics from the University of Melbourne.
Tomas is a member of the MSBase Scientific Leadership Group. Together with the CORe Unit, he is an active participant in the global MSBase collaboration. He has led a number of international collaborative research projects and has contributed to the management of MS globally – including comparative treatment effectiveness, management of treatment failure and individual treatment response. His main research interests span treatment outcomes in MS, individualised therapy, prognostics, epidemiology and utility of volumetric MRI in MS. His research group, CORe, specialises in analytics of observational data in neurology.